These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23793848)

  • 1. LGR5 is a proneural factor and is regulated by OLIG2 in glioma stem-like cells.
    Mao XG; Song SJ; Xue XY; Yan M; Wang L; Lin W; Guo G; Zhang X
    Cell Mol Neurobiol; 2013 Aug; 33(6):851-65. PubMed ID: 23793848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lineage-Restricted OLIG2-RTK Signaling Governs the Molecular Subtype of Glioma Stem-like Cells.
    Kupp R; Shtayer L; Tien AC; Szeto E; Sanai N; Rowitch DH; Mehta S
    Cell Rep; 2016 Sep; 16(11):2838-2845. PubMed ID: 27626655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LGR5 promotes tumorigenicity and invasion of glioblastoma stem-like cells and is a potential therapeutic target for a subset of glioblastoma patients.
    Xie Y; Sundström A; Maturi NP; Tan EJ; Marinescu VD; Jarvius M; Tirfing M; Jin C; Chen L; Essand M; Swartling FJ; Nelander S; Jiang Y; Uhrbom L
    J Pathol; 2019 Feb; 247(2):228-240. PubMed ID: 30357839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable expression of neurogenin 1 induces LGR5, a novel stem cell marker, in an immortalized human neural stem cell line HB1.F3.
    Satoh J; Obayashi S; Tabunoki H; Wakana T; Kim SU
    Cell Mol Neurobiol; 2010 Apr; 30(3):415-26. PubMed ID: 19813087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populations.
    Garner JM; Ellison DW; Finkelstein D; Ganguly D; Du Z; Sims M; Yang CH; Interiano RB; Davidoff AM; Pfeffer LM
    PLoS One; 2015; 10(5):e0125838. PubMed ID: 25955030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of OLIG2 as the most specific glioblastoma stem cell marker starting from comparative analysis of data from similar DNA chip microarray platforms.
    Trépant AL; Bouchart C; Rorive S; Sauvage S; Decaestecker C; Demetter P; Salmon I
    Tumour Biol; 2015 Mar; 36(3):1943-53. PubMed ID: 25384509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ASCL1 Reorganizes Chromatin to Direct Neuronal Fate and Suppress Tumorigenicity of Glioblastoma Stem Cells.
    Park NI; Guilhamon P; Desai K; McAdam RF; Langille E; O'Connor M; Lan X; Whetstone H; Coutinho FJ; Vanner RJ; Ling E; Prinos P; Lee L; Selvadurai H; Atwal G; Kushida M; Clarke ID; Voisin V; Cusimano MD; Bernstein M; Das S; Bader G; Arrowsmith CH; Angers S; Huang X; Lupien M; Dirks PB
    Cell Stem Cell; 2017 Aug; 21(2):209-224.e7. PubMed ID: 28712938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LGR5 is a marker of poor prognosis in glioblastoma and is required for survival of brain cancer stem-like cells.
    Nakata S; Campos B; Bageritz J; Bermejo JL; Becker N; Engel F; Acker T; Momma S; Herold-Mende C; Lichter P; Radlwimmer B; Goidts V
    Brain Pathol; 2013 Jan; 23(1):60-72. PubMed ID: 22805276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of LGR5 suppresses the proliferation of glioma cells in vitro and in vivo.
    Wang D; Zhou J; Fan C; Jiao F; Liu B; Sun P; Miao J; Zhang Q
    Oncol Rep; 2014 Jan; 31(1):41-9. PubMed ID: 24172981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olig2-Dependent Reciprocal Shift in PDGF and EGF Receptor Signaling Regulates Tumor Phenotype and Mitotic Growth in Malignant Glioma.
    Lu F; Chen Y; Zhao C; Wang H; He D; Xu L; Wang J; He X; Deng Y; Lu EE; Liu X; Verma R; Bu H; Drissi R; Fouladi M; Stemmer-Rachamimov AO; Burns D; Xin M; Rubin JB; Bahassi EM; Canoll P; Holland EC; Lu QR
    Cancer Cell; 2016 May; 29(5):669-683. PubMed ID: 27165742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acidic stress promotes a glioma stem cell phenotype.
    Hjelmeland AB; Wu Q; Heddleston JM; Choudhary GS; MacSwords J; Lathia JD; McLendon R; Lindner D; Sloan A; Rich JN
    Cell Death Differ; 2011 May; 18(5):829-40. PubMed ID: 21127501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NF-κB RelB protein is an oncogenic driver of mesenchymal glioma.
    Lee DW; Ramakrishnan D; Valenta J; Parney IF; Bayless KJ; Sitcheran R
    PLoS One; 2013; 8(2):e57489. PubMed ID: 23451236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt/β-catenin pathway and predicts poor survival of glioma patients.
    Zhang J; Cai H; Sun L; Zhan P; Chen M; Zhang F; Ran Y; Wan J
    J Exp Clin Cancer Res; 2018 Sep; 37(1):225. PubMed ID: 30208924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The U2AF2 /circRNA ARF1/miR-342-3p/ISL2 feedback loop regulates angiogenesis in glioma stem cells.
    Jiang Y; Zhou J; Zhao J; Zhang H; Li L; Li H; Chen L; Hu J; Zheng W; Jing Z
    J Exp Clin Cancer Res; 2020 Sep; 39(1):182. PubMed ID: 32894165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway.
    Peng L; Ming Y; Zhang L; Zhou J; Xiang W; Zeng S; He H; Chen L
    FASEB J; 2020 Apr; 34(4):5128-5143. PubMed ID: 32067282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of miR-210 decreases hypoxic glioma stem cells stemness and radioresistance.
    Yang W; Wei J; Guo T; Shen Y; Liu F
    Exp Cell Res; 2014 Aug; 326(1):22-35. PubMed ID: 24930954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant mesenchymal differentiation of glioma stem-like cells: implications for therapeutic targeting.
    Balasubramaniyan V; Vaillant B; Wang S; Gumin J; Butalid ME; Sai K; Mukheef F; Kim SH; Boddeke HW; Lang F; Aldape K; Sulman EP; Bhat KP; Colman H
    Oncotarget; 2015 Oct; 6(31):31007-17. PubMed ID: 26307681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SWIM tool application to expression data of glioblastoma stem-like cell lines, corresponding primary tumors and conventional glioma cell lines.
    Fiscon G; Conte F; Paci P
    BMC Bioinformatics; 2018 Nov; 19(Suppl 15):436. PubMed ID: 30497369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal correlation between YAP1 expression and glioma aggressiveness: clinical and molecular evidence.
    Guichet PO; Masliantsev K; Tachon G; Petropoulos C; Godet J; Larrieu D; Milin S; Wager M; Karayan-Tapon L
    J Pathol; 2018 Oct; 246(2):205-216. PubMed ID: 30009411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity.
    Brown DV; Filiz G; Daniel PM; Hollande F; Dworkin S; Amiridis S; Kountouri N; Ng W; Morokoff AP; Mantamadiotis T
    PLoS One; 2017; 12(2):e0172791. PubMed ID: 28241049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.